Indication of major added benefit for trastuzumab emtansine in metastatic breast canc [Archive]

View Full Version : Indication of major added benefit for trastuzumab emtansine in metastatic breast canc

News

04-10-2014, 02:10 AM

Added benefit not proven in three further subpopulations because appropriate comparator therapies were not implementedThe antibody-drug conjugate trastuzumab emtansine (trade name: Kadcyla) has...

More... (http://www.medicalnewstoday.com/releases/275235.php)